Beam Therapeutics (BEAM) grants president 40,000 restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ciaramella Giuseppe reported acquisition or exercise transactions in this Form 4 filing.
Beam Therapeutics Inc. reported that President Giuseppe Ciaramella received an equity grant of 40,000 restricted stock units (RSUs) of common stock. Each RSU represents the right to receive one Beam share and will vest in four substantially equal annual installments, subject to his continued service. Following this award, he directly holds 230,216 shares of Beam common stock, including the RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ciaramella Giuseppe
Role
President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 40,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 230,216 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
RSUs granted: 40,000 units
Shares following transaction: 230,216 shares
Grant price: $0.0000 per share
+1 more
4 metrics
RSUs granted
40,000 units
Restricted stock units granted on March 31, 2026
Shares following transaction
230,216 shares
Total direct Beam common stock holdings after grant
Grant price
$0.0000 per share
Reported transaction price for RSU grant
Vesting schedule
4 annual installments
RSUs vest over four substantially equal anniversaries
Key Terms
restricted stock units ("RSUs"), 2019 Equity Incentive Plan, vesting
3 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted to the Reporting Person"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2019 Equity Incentive Plan financial
"granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan"
vesting financial
"The RSUs vest in four substantially equal installments on each of the first four anniversaries"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Beam Therapeutics (BEAM) president Giuseppe Ciaramella receive in this Form 4?
Beam Therapeutics’ president Giuseppe Ciaramella received a grant of 40,000 restricted stock units (RSUs). Each RSU represents the contingent right to one share of Beam common stock under the company’s 2019 Equity Incentive Plan, as reported in the Form 4.
How do the 40,000 RSUs granted to BEAM’s president vest over time?
The 40,000 RSUs vest in four substantially equal installments on each of the first four anniversaries of the grant date. Vesting is conditioned on Giuseppe Ciaramella’s continued service with Beam Therapeutics through each applicable vesting date.
What does each RSU granted to Beam Therapeutics’ president represent?
Each RSU granted to Beam Therapeutics’ president represents the contingent right to receive one share of Beam’s common stock. Delivery of the shares occurs as the RSUs vest according to the four-year vesting schedule described in the Form 4 footnote.
Under which plan were the 40,000 RSUs to BEAM’s president granted?
The 40,000 RSUs were granted under the Beam Therapeutics Inc. 2019 Equity Incentive Plan. This plan provides equity-based awards such as restricted stock units to eligible participants as part of their compensation and alignment with shareholder interests.